These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1948542)

  • 41. Antibodies to factor VIII in hemophilia A patients.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies.
    Gatti L; Mannucci PM
    Thromb Haemost; 1984 Jul; 51(3):379-84. PubMed ID: 6437005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hemophilia A with factor VIII inhibitor].
    Shima M
    Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
    [No Abstract]   [Full Text] [Related]  

  • 45. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
    Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD
    Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234
    [No Abstract]   [Full Text] [Related]  

  • 46. The response to factor VIII infusion in inhibitor patients.
    Allain JP; Verroust F
    Prog Clin Biol Res; 1984; 150():99-108. PubMed ID: 6431445
    [No Abstract]   [Full Text] [Related]  

  • 47. The use of porcine factor VIII in Japan.
    Yoshioka A; Shima M; Morichika S; Terada S; Fukui H
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):26-8. PubMed ID: 7939769
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of the bleeding inhibitor patient.
    Astermark J
    Semin Thromb Hemost; 2003 Feb; 29(1):77-86. PubMed ID: 12640569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor VIII inhibitors revisited.
    Bloom AL
    Br J Haematol; 1981 Nov; 49(3):319-24. PubMed ID: 6794594
    [No Abstract]   [Full Text] [Related]  

  • 50. Single-dose pharmacokinetics of porcine factor VIII (Hyate C).
    Hermans C; Owens D; Longo G; Morfini M; Lee CA
    Thromb Haemost; 2002 Feb; 87(2):352-3. PubMed ID: 11858504
    [No Abstract]   [Full Text] [Related]  

  • 51. The development and characterisation of antibodies to human factor VIII in haemophilic dogs.
    Littlewood JD; Barrowcliffe TW
    Thromb Haemost; 1987 Jun; 57(3):314-21. PubMed ID: 3116702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemophilia treatment. Side effects during immune tolerance induction.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Haematologica; 2000 Oct; 85(10 Suppl):75-7. PubMed ID: 11187878
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibodies to heterologous proteins in hemophilia A patients receiving recombinant factor VIII (Recombinate).
    Ingerslev J; Christiansen K; Ravn HB; Bray GL; Gomperts ED;
    Thromb Haemost; 2002 Apr; 87(4):626-34. PubMed ID: 12008945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-stimulation blockade, hemophilic inhibitors and tolerance.
    Qian J; Saenko E; Scott D
    Thromb Haemost; 2001 Dec; 86(6):1343-4. PubMed ID: 11776296
    [No Abstract]   [Full Text] [Related]  

  • 55. Antibodies to factor VIII: specificity and kinetics of iso- and hetero-antibodies in hemophilia A.
    Allain JP; Frommel D
    Blood; 1974 Sep; 44(3):313-22. PubMed ID: 4604102
    [No Abstract]   [Full Text] [Related]  

  • 56. Tolerance and intolerance to factor VIII: a clinical perspective.
    Briët E
    Adv Exp Med Biol; 1995; 386():193-9. PubMed ID: 8851028
    [No Abstract]   [Full Text] [Related]  

  • 57. Immune tolerance to Factor VIII: the international registry data.
    Mariani G; Hilgartner M; Thompson AR; Tusell J; Manco-Johnson M; Ghirardini A; Bellocco R; Brackmann HH
    Adv Exp Med Biol; 1995; 386():201-8. PubMed ID: 8851029
    [No Abstract]   [Full Text] [Related]  

  • 58. Factor VIII inhibitors.
    Lollar P; Healey JF; Barrow RT; Parker ET
    Adv Exp Med Biol; 2001; 489():65-73. PubMed ID: 11554592
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a case.
    White GC; Taylor RE; Blatt PM; Roberts HR
    Blood; 1983 Jul; 62(1):141-5. PubMed ID: 6407545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factor VIII inhibitors in previously treated hemophilic patients.
    Mannucci PM
    J Thromb Haemost; 2011 Nov; 9(11):2328-9. PubMed ID: 21929691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.